Stock OGN ORGANON & CO.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse
Other stock markets
 04:00:02 2024-06-07 pm EDT 		5-day change 1st Jan Change
20.75 USD +0.39% Intraday chart for Organon & Co. -2.72% +43.90%
May. 24 Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation MT
May. 24 Shanghai Henlius Biotech, Inc. and Organon Announces That the European Medicines Agency Has Validated the Marketing Authorization Applications for Hlx14 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ORGANON & CO. Stock Organon & Co.
 5.34B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 765B
JOHNSON & JOHNSON Stock Johnson & Johnson
 354B - - - -
MERCK & CO., INC. Stock Merck & Co., Inc.
 331B
ABBVIE INC. Stock AbbVie Inc.
 299B
ASTRAZENECA PLC Stock AstraZeneca PLC
 248B
  1. Stock Market
  2. Equities
  3. OGN Stock
  4. Charts Organon & Co.
  5. Sector Chart